Heartbeat Health, Inc.

Based in the US, Heartbeat Health, Inc. is a provider of innovative virtual-first cardiology services, enhancing access to cardiovascular care across the nation through remote diagnostics and tailored patient monitoring solutions. Heartbeat Health, Inc. focuses on delivering advanced virtual cardiology services aimed at improving patient health outcomes.

Founded in 2017 and headquartered in New York, US, the company has successfully completed 4 funding deals, raising a total of USD 25. 00 mn. The latest funding round, a Series B, occurred on July 9, 2024, securing USD 20. 00 mn, led by Echo Health Ventures alongside other investors like .

406 Ventures and DaVita Venture Group. The company was co-founded by Aakriti Gupta, Jeff Wessler, Kanyi Maqubela, and others, with Jeff Wessler currently serving as CEO. Heartbeat Health specializes in virtual-first cardiology services designed to improve access to quality cardiovascular care for patients across the United States. The company employs a team of highly trained cardiologists, advanced practitioners, and support staff to deliver remote diagnostics and evidence-based care protocols.

Their primary offerings include comprehensive cardiovascular assessments, home-based diagnostics, and ongoing patient monitoring designed to identify and address gaps in care. Heartbeat Health targets high-risk populations, focusing on improving health outcomes and reducing hospitalizations due to heart conditions, ensuring coverage for patients in all 50 states who may face challenges in accessing traditional cardiology clinics due to geographical constraints. Heartbeat Health generates revenue through partnerships with health plans and accountable care organizations (ACOs). Their transactional structure revolves around subscription-based services for healthcare providers and patients, facilitating ongoing access to cardiovascular care and monitoring tools.

The company engages directly with consumers, enabling patients to enroll in their virtual cardiology program and receive personalized care plans. The use of client-provided claims data and medical records supports a targeted approach to care, enhancing patient engagement and adherence. While specific pricing plans for these services have not been disclosed, the focus remains on delivering high-value care while minimizing costs associated with facility fees and hospitalizations. In July 2024, Heartbeat Health, Inc.

raised an undisclosed amount in growth capital funding from new investor Cressey & Company, with support from existing investors such as . 406 Ventures, Echo Health Ventures, Kindred Ventures, and Optum Ventures. This funding will be leveraged to expand the company's market reach and enhance research and development efforts. Heartbeat Health is focused on introducing new products and services designed to further improve cardiovascular care and is exploring opportunities in new markets, although specific regions and release dates have yet to be publicly detailed.